These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20660408)

  • 1. Goodpasture's disease--new secrets revealed.
    Salant DJ
    N Engl J Med; 2010 Jul; 363(4):388-91. PubMed ID: 20660408
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
    Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
    N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
    Borza DB; Hudson BG
    Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quaternary epitopes of α345(IV) collagen initiate Alport post-transplant anti-GBM nephritis.
    Olaru F; Luo W; Wang XP; Ge L; Hertz JM; Kashtan CE; Sado Y; Segal Y; Hudson BG; Borza DB
    J Am Soc Nephrol; 2013 May; 24(6):889-95. PubMed ID: 23620401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
    Brainwood D; Kashtan C; Gubler MC; Turner AN
    Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
    Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
    J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alport's syndrome, Goodpasture's syndrome, and type IV collagen.
    Hudson BG; Tryggvason K; Sundaramoorthy M; Neilson EG
    N Engl J Med; 2003 Jun; 348(25):2543-56. PubMed ID: 12815141
    [No Abstract]   [Full Text] [Related]  

  • 8. Linear anti-glomerular basement membrane IgG but no glomerular disease: Goodpasture's syndrome restricted to the lung.
    Sethi S; Lewin M; Lopez L; Lager D
    Nephrol Dial Transplant; 2007 Apr; 22(4):1233-5. PubMed ID: 17277338
    [No Abstract]   [Full Text] [Related]  

  • 9. The case of the two disparate diseases: a medical mystery. Part 2.
    Helderman JH
    Am J Nephrol; 1991; 11(3):238-48. PubMed ID: 1962670
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular Analysis of Goodpasture's Disease Following Hematopoietic Stem Cell Transplant in a Pediatric Patient, Recalls the Conformeropathy of Wild-Type Anti-GBM Disease.
    Gray PE; McCarthy H; Siggs OM; Saleem MA; O' Brien T; Frith K; Ziegler JB; Kitching AR; Fogo AB; Hudson BG; Pedchenko V
    Front Immunol; 2019; 10():2659. PubMed ID: 31798588
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
    Ooi JD; Holdsworth SR; Kitching AR
    J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies.
    Charytan D; MacDonald B; Sugimoto H; Pastan S; Staton G; Hennigar R; Kalluri R
    Am J Kidney Dis; 2005 Apr; 45(4):743-8. PubMed ID: 15806477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goodpasture's disease and Alport's syndromes.
    Turner AN; Rees AJ
    Annu Rev Med; 1996; 47():377-86. PubMed ID: 8712789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
    Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
    J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Goodpasture's syndrome as an autoimmune disease--identification of the autoantigen].
    Cohen AD; Shoenfeld Y
    Harefuah; 1995 Jan; 128(2):100-4. PubMed ID: 7721170
    [No Abstract]   [Full Text] [Related]  

  • 16. Alport alloantibodies but not Goodpasture autoantibodies induce murine glomerulonephritis: protection by quinary crosslinks locking cryptic α3(IV) collagen autoepitopes in vivo.
    Luo W; Wang XP; Kashtan CE; Borza DB
    J Immunol; 2010 Sep; 185(6):3520-8. PubMed ID: 20709951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
    Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
    Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Goodpasture's syndrome].
    Nojima Y
    Ryoikibetsu Shokogun Shirizu; 2000; (31):311-3. PubMed ID: 11269091
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulphilimine cross-links in Goodpasture's disease.
    Vanacore R; Pedchenko V; Bhave G; Hudson BG
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):4-6. PubMed ID: 21447121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.